Topics

Fixing a ‘market failure’: To develop new antibiotics, upend the incentive structure, experts urge

04:35 EDT 2 May 2019 | STAT

“It’s a market failure that companies aren’t investing in antimicrobial resistance.”

Original Article: Fixing a ‘market failure’: To develop new antibiotics, upend the incentive structure, experts urge

NEXT ARTICLE

More From BioPortfolio on "Fixing a ‘market failure’: To develop new antibiotics, upend the incentive structure, experts urge"

Quick Search